A Phase II Study Investigating Upfront Pazopanib In Metastatic Renal Cancer Renal Cancer (Panther)

Clinical trial NCT01512186 · UNKNOWN

Trial details

NCT number: NCT01512186
Sponsor: Queen Mary University of London
Status: UNKNOWN
Study type: OBSERVATIONAL

Metastatic Clear Cell Renal Cancer

Start date: 2010-07-01
Primary completion: 2014-02-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.